Henry A Sloviter from 310 Front St, Philadelphia, PA 19106

Address:

Philadelphia, PA 19106

License #:

MD023086L - Expired

Category:

Medicine

Type:

Medical Physician and Surgeon

Process For Prolonging Retention Of Emulsion Particles In The Bloodstream
view source
US Patent:

43978703, Aug 9, 1983
Filed:

Jul 27, 1982
Appl. No.:

6/402449
Inventors:

Henry A. Sloviter - Philadelphia PA
Assignee:

The University of Pennsylvania - Philadelphia PA
International Classification:

A61K 3113
A61K 3102
US Classification:

424325
Abstract:

The retention of coated particles previously infused into the bloodstream of animals may be prolonged by one or more injections of coating substance. For example, the retention of an artificial blood composition comprising emulsified lecithin-coated perfluoro compounds may be prolonged by injection of lecithin.

Process For Preparing Perfluorochemical Emulsion Artificial Blood
view source
US Patent:

44978294, Feb 5, 1985
Filed:

Aug 19, 1983
Appl. No.:

6/524793
Inventors:

Henry A. Sloviter - Philadelphia PA
Assignee:

The University of Pennsylvania - Philadelphia PA
International Classification:

A61K 3113
A61K 3102
US Classification:

514672
Abstract:

Particles of perfluoro compound with a lipid coating are emulsified by sonification in aqueous medium, wherein the proportion of perfluoro compound in the emulsion is preferably about 30-75% (w/v) and the proportion of lipid is preferably about 7-9% (w/v). In the resulting stable emulsion 95% of these particles having diameters less than 0. 2. mu. The emulsion is useful as an artificial blood for transport and delivery of oxygen to body tissues.

Perfluorochemical Emulsion Artificial Blood
view source
US Patent:

44230770, Dec 27, 1983
Filed:

Jul 27, 1982
Appl. No.:

6/402451
Inventors:

Henry A. Sloviter - Philadelphia PA
Assignee:

The University of Pennsylvania - Philadelphia PA
International Classification:

A61K 3113
A61K 31025
US Classification:

424325
Abstract:

Particles of perfluoro compound with a lipid coating are emulsified in aqueous medium, wherein the proportion of perfluoro compound in the emulsion is preferably about 30-75% (w/v) and the proportion of lipid is preferably about 7-9% (w/v). In the resulting stable emulsion 95% of these particles having diameters less than 0. 2. mu. The emulsion is useful as an artificial blood for transport and delivery of oxygen to body tissues.

Henry A Sloviter